Spain. Further to the action taken by the European Agency for the Evaluation of Medicinal Products (EMEA), the Spanish Medicines Agency has suspended the use of medicinal products contain the fluoroquinolone antibiotic, trovafloxacin (Trovan, Turvel: Pfizer, Roerig) and the intravenous formulation of the drug, alatrofloxacin (Trovan IV, Turvel IV: Pfizer, Roerig), with effect from 15 June 1999.
[See also Alert No. 85: Trovafloxacin and alatrofloxacin: serious severe and unpredictable liver injuries dated 27 May 1999 and Alert No. 86: Trovafloxacin and alatrofloxacin: suspension & warnings: hepatotoxicity dated 22 June 1999]
Reference: Communication from the Agencia Española de Medicamento, Ministerio de Sanidad y Consumo, Madrid, 15 June 1999.